A. Junaidi, Sabrina Ermayanti, and Afriani Afriani, “Benefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report”, Bioscmed, vol. 6, no. 14, pp. 2625–2633, Oct. 2022, doi: 10.37275/bsm.v6i14.657.